Rebif (interferon-beta-1a) FDA-approved

    * subcutaneous injection three times a week

    * interferon

    * for relapsing-remitting MS

    * reduces relapse rate

    * side effects: flu like symptoms

    * approved in 2002


 
 
 

Follow Us on Twitter

Follow Us On Twitter - Image